Literature DB >> 19196307

Primary cutaneous melanoma: a complication of infliximab treatment?

I Khan, L Rahman, D B McKenna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19196307     DOI： 10.1111/j.1365-2230.2008.02970.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  6 in total

1.  Malignant transformation of neurocutaneous melanosis (NCM) following immunosuppression.

Authors:  Lauren R Schaff; Ashfaq Marghoob; Marc K Rosenblum; Rina Meyer; Yasmin Khakoo
Journal:  Pediatr Dermatol       Date:  2019-03-13       Impact factor: 1.588

2.  Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review.

Authors:  P Dillon; N Thomas; N Sharpless; F Collichio
Journal:  Med Oncol       Date:  2009-11-05       Impact factor: 3.064

3.  Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.

Authors:  Millie D Long; Christopher F Martin; Clare A Pipkin; Hans H Herfarth; Robert S Sandler; Michael D Kappelman
Journal:  Gastroenterology       Date:  2012-05-11       Impact factor: 22.682

4.  Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?

Authors:  A Finet; M Amini-Adle; B Balme; F Colson; L Thomas
Journal:  Clin Rheumatol       Date:  2012-11-09       Impact factor: 2.980

Review 5.  Development of primary malignant melanoma during treatment with a TNF-α antagonist for severe Crohn's disease: a case report and review of the hypothetical association between TNF-α blockers and cancer.

Authors:  George Kouklakis; Eleni I Efremidou; Michael Pitiakoudis; Nikolaos Liratzopoulos; Alexandros Ch Polychronidis
Journal:  Drug Des Devel Ther       Date:  2013-03-27       Impact factor: 4.162

6.  Dermal Lesions and Skin Cancer in Patients with Inflammatory Bowel Disease Receiving Immunosuppressive Therapy

Authors:  Eftychia Giagkou; Maria Saridi; Eleni Albani; Georgios Gaitanis; Andreas Katsanos; Aris Bechlioulis; Athanasios-Dimitrios Bacasis; Dimitrios K Christodoulou; Konstantinos H Katsanos
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.